loadpatents
name:-0.044248104095459
name:-0.027094125747681
name:-0.0060961246490479
Semple; Graeme Patent Filings

Semple; Graeme

Patent Applications and Registrations

Patent applications and USPTO patent grants for Semple; Graeme.The latest application filed is for "5-ht2c receptor agonists and compositions and methods of use".

Company Profile
6.26.38
  • Semple; Graeme - San Diego CA
  • Semple; Graeme - Molndal SE
  • Semple, Graeme - Billdal SE
  • Semple; Graeme - Gothenburg SE
  • Semple; Graeme - Hamphire GB
  • Semple; Graeme - Hampshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
5-HT.sub.2C receptor agonists and compositions and methods of use
Grant 11,395,824 - Lehmann , et al. July 26, 2
2022-07-26
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20210214355 - Semple; Graeme ;   et al.
2021-07-15
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20200383993 - Lehmann; Juerg ;   et al.
2020-12-10
5-HT2C receptor agonists and compositions and methods of use
Grant 10,836,764 - Semple , et al. November 17, 2
2020-11-17
5-HT.sub.2C receptor agonists and compositions and methods of use
Grant 10,624,900 - Lehmann , et al.
2020-04-21
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20200078368 - Lehmann; Juerg ;   et al.
2020-03-12
5-HT.sub.2C receptor agonists and compositions and methods of use
Grant 10,392,390 - Ren , et al. A
2019-08-27
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20190225612 - Semple; Graeme ;   et al.
2019-07-25
5-HT2C receptor agonists and compositions and methods of use
Grant 10,272,094 - Lehmann , et al.
2019-04-30
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20180214455 - Lehmann; Juerg ;   et al.
2018-08-02
5-ht2c Receptor Agonists And Compositions And Methods Of Use
App 20180186797 - Ren; Albert S. ;   et al.
2018-07-05
1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto
Grant 9,676,758 - Xiong , et al. June 13, 2
2017-06-13
1-heteroaryl-indoline-4-carboxamides As Modulators Of Gpr52 Useful For The Treatment Or Prevention Of Disorders Related Thereto
App 20160318911 - Xiong; Yifeng ;   et al.
2016-11-03
Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders
Grant 9,365,511 - Covel , et al. June 14, 2
2016-06-14
Biphenyl-ethyl-pyrrolidine Derivatives As Histamine H3 Receptor Modulators For The Treatment Of Cognitive Disorders
App 20150353488 - Covel; Jonathan A. ;   et al.
2015-12-10
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
Grant 8,933,083 - Jones , et al. January 13, 2
2015-01-13
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
Grant 8,637,555 - Semple , et al. January 28, 2
2014-01-28
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 8,546,429 - Jones , et al. October 1, 2
2013-10-01
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 8,410,119 - Jones , et al. April 2, 2
2013-04-02
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
App 20130023527 - Jones; Robert M. ;   et al.
2013-01-24
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
Grant 8,293,751 - Jones , et al. October 23, 2
2012-10-23
1,2,3-trisubstituted Aryl And Heteroaryl Derivatives As Modulators Of Metabolism And The Prophylaxis And Treatment Of Disorders Related Thereto
App 20110112060 - Jones; Robert M. ;   et al.
2011-05-12
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
App 20110082134 - JONES; Robert M. ;   et al.
2011-04-07
Modulators Of The Histamine H3 Receptor Useful For The Treatment Of Disorders Related Thereto
App 20100331312 - Santora; Vincent J. ;   et al.
2010-12-30
4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
Grant 7,803,837 - Jung , et al. September 28, 2
2010-09-28
Biphenyl Sulfonyl And Phenyl-heteroaryl Sulfonyl Modulators Of The Histamine H3-receptor Useful For The Treatment Of Disorders Related Thereto
App 20100240653 - Santora; Vincent J. ;   et al.
2010-09-23
Fused-aryl And Heteroaryl Derivatives As Modulators Of Metabolism And The Prophylaxis And Treatment Of Disorders Related Thereto
App 20100093761 - Jones; Robert M. ;   et al.
2010-04-15
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 7,625,906 - Jones , et al. December 1, 2
2009-12-01
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
Grant 7,612,106 - Boatman , et al. November 3, 2
2009-11-03
Fused Pyrazole Derivatives And Methods Of Treatment Of Metabolic-related Disorders Thereof
App 20090258892 - Boatman; P. Douglas ;   et al.
2009-10-15
Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20090036434 - Jones; Robert M. ;   et al.
2009-02-05
Pyrimidine Derivatives And Methods Of Treatment Related To The Use Thereof
App 20090036448 - Sekiguchi; Yoshinori ;   et al.
2009-02-05
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 7,470,699 - Jones , et al. December 30, 2
2008-12-30
4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
App 20070161701 - Jung; Jae-Kyu ;   et al.
2007-07-12
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
Grant 7,241,792 - Boatman , et al. July 10, 2
2007-07-10
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto
App 20070155763 - Jones; Robert M. ;   et al.
2007-07-05
4-Oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
App 20070093545 - Jung; Jae-Kyu ;   et al.
2007-04-26
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20070082874 - Jones; Robert M. ;   et al.
2007-04-12
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
App 20070072924 - Semple; Graeme ;   et al.
2007-03-29
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20070072844 - Jones; Robert M. ;   et al.
2007-03-29
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
App 20070073062 - Boatman; P. Douglas ;   et al.
2007-03-29
Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
App 20070066590 - Jones; Robert M. ;   et al.
2007-03-22
Fused azepine derivatives and their use as antidiuretic agents
Grant 7,176,195 - Ashworth , et al. February 13, 2
2007-02-13
5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases
App 20070032537 - Semple; Graeme ;   et al.
2007-02-08
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Grant 7,132,426 - Jones , et al. November 7, 2
2006-11-07
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
App 20060217379 - Jones; Robert M. ;   et al.
2006-09-28
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
App 20060217562 - Semple; Graeme ;   et al.
2006-09-28
Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
App 20060205955 - Boatman; P. Douglas ;   et al.
2006-09-14
5-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia
App 20060167270 - Semple; Graeme ;   et al.
2006-07-27
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20060142262 - Jones; Robert M. ;   et al.
2006-06-29
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
App 20060122240 - Semple; Graeme ;   et al.
2006-06-08
Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
App 20050197350 - Sekiguchi, Yoshinori ;   et al.
2005-09-08
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20050070562 - Jones, Robert M. ;   et al.
2005-03-31
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
App 20050059650 - Jones, Robert M. ;   et al.
2005-03-17
Novel pyridinone and related heterocyclic derivatives
App 20040186104 - Johansson, Magnus ;   et al.
2004-09-23
Fused azepine derivatives and their use as antidiuretic agents
App 20040038962 - Ashworth, Doreen ;   et al.
2004-02-26
GnRH antagonists being modified in positions 5 and 6
Grant 6,214,798 - Semple , et al. April 10, 2
2001-04-10
GnRH antagonist decapeptides
Grant 5,821,230 - Jiang , et al. October 13, 1
1998-10-13
Process of preparing benzodiazepine compounds useful as antagonists of CCK or of gastrine
Grant 5,728,829 - Semple , et al. March 17, 1
1998-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed